GAMIDA CELL LTD.

(GMDA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on GAMIDA CELL LTD.
2021Needham Adjusts Price Target on Gamida Cell to $12 from $14, Keeps Buy Rating
MT
2021Oppenheimer Adjusts Gamida Cell PT to $15 From $17, Maintains Outperform Rating
MT
2021RBC Cuts Price Target on Gamida Cell to $11 From $14, Citing Setback to Omidubicel Fili..
MT
2021GAMIDA CELL : RBC Capital Adjusts Gamida Cell PT to $14 From $12, Maintains Outperform - S..
MT
2021GAMIDA CELL : Needham Adjusts Price Target on Gamida Cell to $14 From $17, Maintains Buy R..
MT
2020GAMIDA CELL : Oppenheimer Adjusts Gamida Cell PT to $17 From $20, Maintains Outperform Rat..
MT
2020GAMIDA CELL : RBC Capital Adjusts Gamida Cell's Price Target to $12 From $13, Maintains Ou..
MT
Upcoming event on GAMIDA CELL LTD.